The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $45.90

Today's change+1.81 +4.11%
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $45.90

Today's change+1.81 +4.11%
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.

Sanofi SA Hits New 52-week High

Sanofi SA closed up sharply Monday, rallying (U.S.)$1.81 or 4.11% to (U.S.)$45.90 and setting a new 52-week high. Over the last five days, shares have gained 0.81% and 13.50% year to date. Shares have underperformed the S&P 500 by 9.66% during the last year.

Key company metrics

  • Open(U.S.) $46.11
  • Previous close(U.S.) $44.09
  • High(U.S.) $46.16
  • Low(U.S.) $45.72
  • Bid / Ask(U.S.) $45.79 / (U.S.) $45.95
  • YTD % change+13.50%
  • Volume3,973,977
  • Average volume (10-day)1,293,604
  • Average volume (1-month)1,329,497
  • Average volume (3-month)1,682,521
  • 52-week range(U.S.) $36.81 to (U.S.) $46.16
  • Beta1.00
  • Trailing P/E25.24×
  • P/E 1 year forward14.54×
  • Forward PEG2.08×
  • Indicated annual dividend(U.S.) $1.58
  • Dividend yield3.44%
  • Trailing EPS(U.S.) $1.82
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.54%

Based on its net profit margin of 12.54%, Sanofi SA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.63%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue18,4729,29516,2367,928
Total other revenue--------
Total revenue18,4729,29516,2367,928
Gross profit12,7406,51911,2665,481
Total cost of revenue5,7322,7764,9702,447
Total operating expense15,0036,90413,6586,774
Selling / general / administrative4,8772,2744,6092,212
Research & development2,6581,2212,5141,235
Depreciation / amortization815403877444
Interest expense (income), net operating--------
Unusual expense (income)65684691500
Other operating expenses, total265146-3-64
Operating income3,4692,3912,5781,154
Interest income (expense), net non-operating-170---190--
Gain (loss) on sale of assets--------
Other--------
Income before tax3,2792,1472,3991,037
Income after tax2,4501,6871,902920
Income tax, total829460497117
Net income2,4641,6742,2451,087
Total adjustments to net income--------
Net income before extra. items2,4361,6641,959987
Minority interest-50-29-41-26
Equity in affiliates3669893
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,4361,6641,959987
Inc. avail. to common incl. extra. items2,4641,6742,2451,087
Diluted net income2,4641,6742,2451,087
Dilution adjustment--------
Diluted weighted average shares1,2951,2891,2971,288
Diluted EPS excluding extraordinary itemsvalue per share1.881.291.510.77
Dividends per sharevalue per share2.960.000.000.00
Diluted normalized EPSvalue per share2.261.341.931.11